Remdesivir is the IV medication recommended by Dr Fauci! Its very bad!!
RT @dockaurG: “60% reported adverse events during follow-up. ~25% of #COVID19 pts receiving #remdesivir had severe side effects, incl multi…
RT @dockaurG: “60% reported adverse events during follow-up. ~25% of #COVID19 pts receiving #remdesivir had severe side effects, incl multi…
RT @dockaurG: “60% reported adverse events during follow-up. ~25% of #COVID19 pts receiving #remdesivir had severe side effects, incl multi…
RT @dockaurG: “60% reported adverse events during follow-up. ~25% of #COVID19 pts receiving #remdesivir had severe side effects, incl multi…
“60% reported adverse events during follow-up. ~25% of #COVID19 pts receiving #remdesivir had severe side effects, incl multiple-organ dysfunction syndrome, septic shock, acute renal injury & hypotension. ~23% demonstrated lab evidence of hepatic damag
RT @CorinneReverbel: 2/2 Rappelons quand même que les seules études publiées sur le #remdesivir disent 1- que cela ne marche pas https://t…
RT @CorinneReverbel: 2/2 Rappelons quand même que les seules études publiées sur le #remdesivir disent 1- que cela ne marche pas https://t…
RT @CorinneReverbel: 2/2 Rappelons quand même que les seules études publiées sur le #remdesivir disent 1- que cela ne marche pas https://t…
RT @CorinneReverbel: 2/2 Rappelons quand même que les seules études publiées sur le #remdesivir disent 1- que cela ne marche pas https://t…
RT @CorinneReverbel: 2/2 Rappelons quand même que les seules études publiées sur le #remdesivir disent 1- que cela ne marche pas https://t…
RT @CorinneReverbel: 2/2 Rappelons quand même que les seules études publiées sur le #remdesivir disent 1- que cela ne marche pas https://t…
RT @CorinneReverbel: 2/2 Rappelons quand même que les seules études publiées sur le #remdesivir disent 1- que cela ne marche pas https://t…
RT @CorinneReverbel: 2/2 Rappelons quand même que les seules études publiées sur le #remdesivir disent 1- que cela ne marche pas https://t…
RT @CorinneReverbel: 2/2 Rappelons quand même que les seules études publiées sur le #remdesivir disent 1- que cela ne marche pas https://t…
RT @CorinneReverbel: 2/2 Rappelons quand même que les seules études publiées sur le #remdesivir disent 1- que cela ne marche pas https://t…
RT @CorinneReverbel: 2/2 Rappelons quand même que les seules études publiées sur le #remdesivir disent 1- que cela ne marche pas https://t…
2/2 Rappelons quand même que les seules études publiées sur le #remdesivir disent 1- que cela ne marche pas https://t.co/yN4lOdkCBR 2- qu'on observe dans 60% des cas des effets secondaires dont 23% graves https://t.co/MIAhvKSq0G 3-+ fuites sur WHO https
RT @rising_serpent: Patients hospitalized for severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was…
RT @badseedbook: 🔴 PHARMA-WAR & Contradictory News Generic (Chloroquine) vs. New Molecule Meds (GILEAD) China/India vs. U.S./EU Option A…
RT @anesthesiahq: Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/b0vOWRPDzw
RT @fujikurok: よくレムデシビルの’副作用’としてテレビで報道されている多臓器不全や急性腎障害の元ネタはこれ? NEJM論文 Compassionate Use of Remdesivir for Patients with Severe Covid-19 htt…
重症Covid19患者に対するRemdesivirの人道的使用。 臨床的改善(酸素化能)は68%に認めた。死亡率は18日間のフォローで13%だった。(April 10,2020) https://t.co/qPxaiAAkHe
@BanidoLuca @exame Então o resultado foi melhor que o tal Remdesivir que teve taxa de mortalidade de 18%?!! https://t.co/I1Z60EEn23
@TeichNelson Efeitos colaterais do Remdesivir. Fonte : https://t.co/Tki39rHobI https://t.co/CIBRhi5Tt3
@incoqunito @YouTube Ich begreife das Unbehagen gegen Teile der Schulmedizin. "Bibel" , New England Journal of Medicine: In einer vom Hersteller (Gilead) finanzierten, UNKONTROLLIERTEN Studie... https://t.co/sdSAe205wu
@Scheibenwischan Ich begreife das Unbehagen gegen Teile der Schulmedizin. "Bibel" , New England Journal of Medicine: In einer vom Hersteller (Gilead) finanzierten, UNKONTROLLIERTEN Studie... https://t.co/sdSAe205wu
#Remdesivir erweist sich als wirksam gegen das neue #Coronavirus: https://t.co/yGDhGVRmFt Bei der Vervielfältigung der viralen RNA wird die Substanz von der viralen RNA-Polymerase als falsches Bauteil anstelle von Adenosin eingebaut und es kommt zum Ketten
https://t.co/dHnavDSjIS 国立国際医療センター、東京(NO)、東京湾浦安市川医療センター、浦安市(RO)、平塚市病院、平塚(KY)、横浜市立大学病院、横浜(HK)、群馬大学病院、群馬(TM)、陶生病院、瀬戸(Y. M.)—すべて日本国内
RT @badseedbook: 🔴 PHARMA-WAR & Contradictory News Generic (Chloroquine) vs. New Molecule Meds (GILEAD) China/India vs. U.S./EU Option A…
🔴 PHARMA-WAR & Contradictory News Generic (Chloroquine) vs. New Molecule Meds (GILEAD) China/India vs. U.S./EU Option A (cheap) 👉https://t.co/k6Zo6ePbnn Option B (Expensive) 👉https://t.co/XbRbV8hEvf https://t.co/2WMhibdFt4
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/ZZJrgpQXKp
@RMargot8 @CNN Is just another antiviral drug it just works better than the rest. https://t.co/tduRXFNDDt
RT @WaltiSiegrist: Ich begreife das Unbehagen gegen Teile der Schulmedizin. "Bibel" , New England Journal of Medicine: In einer vom Herstel…
Ich begreife das Unbehagen gegen Teile der Schulmedizin. "Bibel" , New England Journal of Medicine: In einer vom Hersteller (Gilead) finanzierten, UNKONTROLLIERTEN Studie... https://t.co/sdSAe205wu
RT @surgababy: https://t.co/G0BSKaohwV Patients with severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvem…
https://t.co/G0BSKaohwV Patients with severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was observed in 36 of 53 patients (68%) There's still hope, though. Mungkin ada ekspansi global supply untuk Remdesivir.
よくレムデシビルの’副作用’としてテレビで報道されている多臓器不全や急性腎障害の元ネタはこれ? NEJM論文 Compassionate Use of Remdesivir for Patients with Severe Covid-19 https://t.co/nNUb5zSZ1o
@aevanko @Lonesteban Here is the research that the NHK article is quoting: https://t.co/FUkPTfaaTx
@jiaonian https://t.co/xzaWtdTu2C これですかね?多臓器不全を含む重篤な副作用は23%で起きていますね。ただクロロキンの場合は心停止や突然死に至る例も出ているようです。レムデシビルも決して安全だと言うわけではないですが、クロロキンの突然死リスクは使うのを躊躇う理由にはなるかと考えます。
#COVID19 is now showing effects on the kidney and given the treatment being advised has adverse effects of multiple organ dysfunction syndrome and acute kidney injury...maybe we dont rush $GILD? https://t.co/ZXc18Qv8RW https://t.co/x5llKH5IsF
@tanu7013 @toyo12092 #zoom1242 (´-`).。oO 対してレムデシビルの副作用 (英語) https://t.co/v6e273aNte
RT @thelonevirologi: Compassionate Use of Remdesivir for Patients with Severe Covid-19 https://t.co/wC2kGZcLB3
RT @Ryu237244338: @FEcIJko2lHdZtzq @mei98862477 お待たせです〰️ レムデシビル臨床試験データです https://t.co/5VxpDkxrX8 https://t.co/44mRhYBzNf
RT @GarridoLagunaMD: I am afraid this compassionate #COVID19 remdesivir @NEJM is not all that promising nearly 50% of patients could not b…
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/HQNyvzwu9F
RT @Ryu237244338: @FEcIJko2lHdZtzq @mei98862477 お待たせです〰️ レムデシビル臨床試験データです https://t.co/5VxpDkxrX8 https://t.co/44mRhYBzNf
@kyodo_official 承認されるから、適正使用になるので副作用は救済制度で国が責任持つんですよね…。心配です。 https://t.co/gIyZ7tll0u https://t.co/0QSTdlURj7
RT @kidney_boy: Ladies and gentleman, I think we have a therapy. https://t.co/QpN0tKFSfo https://t.co/WDCpgLwU0A
@FEcIJko2lHdZtzq @mei98862477 お待たせです〰️ レムデシビル臨床試験データです https://t.co/5VxpDkxrX8 https://t.co/44mRhYBzNf
@docneto Here's another article but the sample size is smaller than in the previous article and the criteria to define "improvement" is different. https://t.co/eDjx787wHQ
This follows the publication of another confusing paper (a case series of 61 patients) on the same treatment (impressed?) in @NEJM https://t.co/N4KWBYmiCQ
RT @UNMC_PCCM: #PCCM Journal Club today! First article from Dr. Davidson, NEJM Compassionate Use of Remdesivir: https://t.co/C01qxHOn7c
Compassionate use of Remdesivir shows promising signs for a potential COVID-19 treatment https://t.co/l5NWthO2tn
RT @UNMC_PCCM: #PCCM Journal Club today! First article from Dr. Davidson, NEJM Compassionate Use of Remdesivir: https://t.co/C01qxHOn7c
#PCCM Journal Club today! First article from Dr. Davidson, NEJM Compassionate Use of Remdesivir: https://t.co/C01qxHOn7c
新型コロナについてレムデシビル承認するのか。こんな性急に決めて大丈夫なのかな。アメリカの臨床研究では34例中9名になんらかのserious adverse eventが確認されてる。https://t.co/wFdzQVss7F adverse eventなので薬との因果関係が確定したわけではないのだろうけど。1/n
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
@_8rar تجد في السلسة ... عن الدواء🌷 https://t.co/AojiszgVeB
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/E6v6EaJTpe Setidaknya BPOM AS telah menyetujui pemakaian Remdesivir jadi obat penanganan pasien Covid-19. Step by step, mentari sudah mulai terbit.😍
American Medical Association Compassionate Use of Remdesivir for Patients with Severe Covid-19 https://t.co/T1mnWK0yqC
@GatunaGuerrera He visto mas información y hay posibilidades. https://t.co/4MByTPacsl
Cuatro semanas después, el remdesivir arrojó resultados preliminares, pero alentadores: 36 de los 53 pacientes con covid-19 (22 de EE.UU., 22 entre UE y Canadá, 7 en Japón) a los que se les aplicó el medicamento tuvieron mejora clínica. https://t.co/XLP5I
RT @ZinClaudio: Gracias Manuel muchas gracias. Fauci la pidió a Gilead que garantice stock, cosa que no pueden hacer. Por ende NADIE autori…
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/O8gb6aQ4Ng
RT @LeventalLab: OH WOW! This looks to be fantastic news! No wonder Gilead was ramping up production.
急性腎不全2-4割ってこれか?lancetとは患者の重症度が若干違う気もしちゃうな。気管支挿管とかECMOの状態なら急性腎不全とか言ってないでレムデシビル入れるしかないかも。あとはヘパリンは併用しておいた方がいいかも? https://t.co/UL7juIHrgq
"funded by Gilead"😒
@StockPriceBro1 @mathewgoldsholl @DrEricDing It does not suggest anything. You can’t blame the drug when the diseases causes these conditions. That’s why you need a placebo group to determine side effects. Read the study. It says nothing about side eff
Gracias Manuel muchas gracias. Fauci la pidió a Gilead que garantice stock, cosa que no pueden hacer. Por ende NADIE autorizo el uso, más que compasivo para pacientes COVID 19. Para los no médicos REMDESIVIR no está aprobado en ningún país del mundo. Nunc
@DeryaTR_ NEJM'deki yayina gore remdesivir kullaniminda, 53 COVID hastasindan sadece 36'sinda iyilesme goruldu @DeryaTR_ https://t.co/PcZLG8hI3V
@mehmetcilingiro cok etkin bir ilac degil NEJM'deki yayina gore iyilestirme orani %68 @mehmetcilingiro https://t.co/PcZLG8ziVt
Peer review: New England Journal of Medicine "Measurement of efficacy will require ongoing randomized, placebo-controlled trials of remdesivir therapy." https://t.co/E88pCza0ND
@GulsanSucak Pubmedde gördüğümüz yanlış ve yönlendirilmiş düşük kalite makale nedir hocam? Örnek vermeden anlayamayız. Mesala aşağıdaki makele sizin bu tanımınıza uyuyor mu? Konumunuzu anlıyorum ancak insanların taşın altına elini koyma zamanı gelmedi mi
@aurelienlambert @a_1_0_2 @MartineWonner @CorinneReverbel @IHUStrasbourg @IHU_Marseille @Laissonslespre1 @pdousteblazy @ars_grand_est Le système publication est soumis à une logique éditoriale qui n'a rien de scientifique Exemple cette étude Gilead sur rem
RT @CorinneReverbel: ATTENTION AUX ANNONCES DE GILEAD ➡️Ne pas oublier ce qui est publié sur Remdesivir dans NEJM ⚠️Toxicité du #Remdesivi…
RT @CorinneReverbel: ATTENTION AUX ANNONCES DE GILEAD ➡️Ne pas oublier ce qui est publié sur Remdesivir dans NEJM ⚠️Toxicité du #Remdesivi…
RT @EMSwami: Leaked RCT data @GileadSciences shows no benefit to remdesivir https://t.co/MzvYAWXfSa Spokesperson states: too few patients…
@LolaMerino6 @el_pais Así es. Y puede que también la capacidad de influencia de las multinacionales farmacéuticas. Ello hace que se publiquen estudios de nefasta metodologia en revistas del mas alto nivel @NEJM https://t.co/Nzy3Y9FYup
RT @Alvaro_Taype: 📗 Se publica un paper en NEJM en el cual se brinda Remdesivir como uso compasivo a 53 pacientes, de los cuales 36 mejoran…
@takeheight #Remdevisir ne marche pas https://t.co/yN4lOd31Kj Et 60% d’effets secondaires dont 23% d’effets secondaires graves https://t.co/w9hZ7snwUU C’est pas moi qui le dit, c’est dans les articles 😱
RT @rbganatra: 1/ Should we use #remdesivir (RDV) to treat #COVID19 #SARSCoV2? Let’s take a look at the data. Here’s: #HowIReadThisPaper…
RT @MedicalScitech: 🔝Compassionate Use of #Remdesivir for Patients with Severe #COVID19 » https://t.co/jat1dDmkiU Clinical improvement was…
RT @robertpdickson: Here's NEJM creating false hope for remdesivir by publishing a study without a control arm. https://t.co/LPim6FeCN3 ht…
RT @robertpdickson: Here's NEJM creating false hope for remdesivir by publishing a study without a control arm. https://t.co/LPim6FeCN3 ht…
Here's NEJM creating false hope for remdesivir by publishing a study without a control arm. https://t.co/LPim6FeCN3 https://t.co/cy13JQnCxO 4/n https://t.co/a3Qbtnpj10
@antonia_romera @PabloFuente @geoestratego juzgue usted: https://t.co/rLtSEyuEBV
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/AO6K7oqIKm
1/ Follow up to my prior tweet with new data (but less clarity than I had hoped https://t.co/9BULKxjkIi
NEJM https://t.co/xyiAz1oDay "In severe COVID-19, remdesivir was not associated with statistically significant clinical benefits... " (10 April 2020)
RT @kidney_boy: Ladies and gentleman, I think we have a therapy. https://t.co/QpN0tKFSfo https://t.co/WDCpgLwU0A